Semaglutide for ADHD: What the Evidence Shows
What human and animal studies show about Semaglutide for ADHD, how strong that evidence is, and what is still unproven.
- Strongest evidence
- None graded
- no study with an outcome for ADHD (PubMed search, 2 Oct 2026)
- Human studies
- None found
- with an outcome for ADHD, in our evidence file (PubMed search, 2 Oct 2026)
- Animal studies
- None found
- with an outcome for ADHD, in our evidence file (PubMed search, 2 Oct 2026)
Evidence for ADHD
None of the study abstracts we summarised for Semaglutide reported an outcome for ADHD (PubMed search, 2 Oct 2026). Claims that it helps with ADHD are unproven.
How strong is it?
A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.
What ADHD is, and why semaglutide is not an ADHD drug
MedlinePlus calls ADHD a neurodevelopmental disorder that usually starts in childhood and often lasts into adulthood, a very different target from the diabetes and obesity populations semaglutide trials enrolled.[12]
We found no trial of semaglutide in people with ADHD; the nearest data are large health-record cohorts that tracked 22 neurological and psychiatric outcomes, and ADHD is not on that list.[13]
The closest evidence: neuropsychiatric safety and eating behaviour
In that 12-month cohort of people with type 2 diabetes, semaglutide was not linked to a higher risk of adverse neuropsychiatric outcomes than other diabetes drugs, which speaks to safety rather than to treating ADHD.[13]
A review of binge eating disorder notes that it is frequently associated with ADHD, depression, bipolar disorder, anxiety disorders, alcohol and nicotine use disorder, and obesity.[14]
Safety wording on the label
The Wegovy label's revision list shows a suicidal behaviour and ideation warning marked as removed, a labelling fact about mood safety and not evidence for ADHD.[15]
Other peptides people research for ADHD
All peptides for ADHD, comparedCommon questions
Does Semaglutide help with ADHD?
None of the studies we summarised for Semaglutide (PubMed search, 2 Oct 2026) measured an outcome for ADHD. Treat claims that it helps with ADHD as unproven.
Is Semaglutide approved for ADHD?
Semaglutide is FDA approved (Ozempic, Wegovy, Rybelsus). Which conditions that approval covers is set by the label; use for anything else is off-label.
What is the best peptide for ADHD?
There is no single answer. Our ADHD overview compares each candidate by evidence grade and legal status rather than by popularity.
Can semaglutide help with ADHD?
We found no trial of semaglutide for ADHD, so there is no evidence either way. The studies that exist looked at neurological and psychiatric safety in people with diabetes.[13]
More on Semaglutide
Sources
- 1PubMed search: semaglutide[ti] AND (STEP OR "once-weekly semaglutide in adults with overweight or obesity" OR "Semaglutide 2.4 mg") AND randomized controlled trial[pt] (136 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 2PubMed search: semaglutide[ti] AND (cardiovascular outcomes OR "SELECT" OR "SUSTAIN" OR "PIONEER 6" OR "myocardial infarction") (560 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 3PubMed search: semaglutide[ti] AND (kidney OR FLOW OR "steatohepatitis" OR ESSENCE OR "heart failure" OR "knee osteoarthritis" OR Alzheimer) (590 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 4PubMed search: semaglutide[tiab] AND (meta-analysis[pt] OR systematic review[pt]) AND (weight OR obesity OR cardiovascular OR HbA1c) (361 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 5PubMed search: semaglutide[tiab] AND (pharmacokinetic*[tiab] OR half-life[tiab]) AND humans[mh] (136 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 6PubMed search: semaglutide[ti] AND (chronic kidney disease OR "knee osteoarthritis") AND randomized controlled trial[pt] (27 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 7PubMed search: semaglutide[tiab] AND (depress*[ti] OR suicid*[ti] OR "psychiatric"[ti] OR Alzheimer*[ti] OR cognit*[ti]) (159 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 8PubMed search: semaglutide[tiab] AND (blood pressure[ti] OR lipid*[ti] OR cholesterol[ti] OR "visceral"[ti] OR "waist"[ti] OR "body composition"[ti]) (112 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 9PubMed search: semaglutide[tiab] AND (rheumatoid[tiab] OR "psoriatic"[tiab] OR "inflammation"[ti] OR "C-reactive"[ti]) (60 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 10PubMed search: semaglutide[ti] AND ("knee osteoarthritis" OR "osteoarthritis" OR "obesity-related") AND (pain OR knee) (17 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 11PubMed search: semaglutide[tiab] AND (Alzheimer*[tiab] OR evoke[tiab]) AND (randomized controlled trial[pt] OR clinical trial[pt]) (3 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 12Official web pageOfficial web page · web page
- 1312-month neurological and psychiatric outcomes of semaglutide use for type 2 diabetes: a propensity-score matched cohort study.EClinicalMedicine · 2024PMID 39764175Accessed 2 Oct 2026
- 14Pharmacological Treatment of Binge Eating Disorder and Frequent Comorbid Diseases.CNS drugs · 2024PMID 39096466Accessed 2 Oct 2026
- 15WEGOVY prescribing information (FDA label)FDA label, DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026
Found an error? Report a correction.